BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24916573)

  • 1. The adenocarcinoma cell surface mucin receptor for alpha-fetoprotein: is the same receptor present on circulating monocytes and macrophages? A commentary.
    Mizejewski GJ
    Tumour Biol; 2014 Aug; 35(8):7397-402. PubMed ID: 24916573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor.
    Mizejewski GJ
    Tumour Biol; 2013 Jun; 34(3):1317-36. PubMed ID: 23446764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and partial characterization of a specific alpha-fetoprotein receptor on human monocytes.
    Suzuki Y; Zeng CQ; Alpert E
    J Clin Invest; 1992 Oct; 90(4):1530-6. PubMed ID: 1383274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of an alpha-fetoprotein/receptor pathway in human normal and malignant peripheral blood mononuclear cells.
    Esteban C; Trojan J; Macho A; Mishal Z; Lafarge-Frayssinet C; Uriel J
    Leukemia; 1993 Nov; 7(11):1807-16. PubMed ID: 7694005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the putative cell-surface receptors for alpha-fetoprotein: identification of a candidate receptor protein family.
    Mizejewski GJ
    Tumour Biol; 2011 Apr; 32(2):241-58. PubMed ID: 21120646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
    Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H
    Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human alpha-fetoprotein binds to primary macrophages.
    Atemezem A; Mbemba E; Marfaing R; Vaysse J; Pontet M; Saffar L; Charnaux N; Gattegno L
    Biochem Biophys Res Commun; 2002 Aug; 296(3):507-14. PubMed ID: 12176010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.
    Jerome KR; Barnd DL; Bendt KM; Boyer CM; Taylor-Papadimitriou J; McKenzie IF; Bast RC; Finn OJ
    Cancer Res; 1991 Jun; 51(11):2908-16. PubMed ID: 1709586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies directed against a widespread oncofetal antigen: the alpha-fetoprotein receptor.
    Moro R; Tamaoki T; Wegmann TG; Longenecker BM; Laderoute MP
    Tumour Biol; 1993; 14(2):116-30. PubMed ID: 7687070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of high-molecular-weight human salivary mucins.
    Offner GD; Troxler RF
    Adv Dent Res; 2000 Dec; 14():69-75. PubMed ID: 11842927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha-fetoprotein third domain receptor binding fragment: in search of scavenger and associated receptor targets.
    Mizejewski GJ
    J Drug Target; 2015; 23(6):538-51. PubMed ID: 25766080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of alpha-fetoprotein receptors by human T-lymphocytes during blastic transformation.
    Torres JM; Laborda J; Naval J; Darracq N; Calvo M; Mishal Z; Uriel J
    Mol Immunol; 1989 Sep; 26(9):851-7. PubMed ID: 2481232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the Third Domain Receptor Binding Fragment of Alphafetoprotein (AFP): Plausible Binding of AFP to Lysophospholipid Receptor Targets.
    Mizejewski GJ
    Curr Drug Targets; 2017; 18(7):874-886. PubMed ID: 26844573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple hepatic receptors cooperate to eliminate secretory mucins aberrantly entering the bloodstream: are circulating cancer mucins the "tip of the iceberg"?
    Wahrenbrock MG; Varki A
    Cancer Res; 2006 Feb; 66(4):2433-41. PubMed ID: 16489050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
    Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
    J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human epidermal growth factor (EGF) module-containing mucin-like hormone receptor 3 is a new member of the EGF-TM7 family that recognizes a ligand on human macrophages and activated neutrophils.
    Stacey M; Lin HH; Hilyard KL; Gordon S; McKnight AJ
    J Biol Chem; 2001 Jun; 276(22):18863-70. PubMed ID: 11279179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-fetoprotein signal sequences: a proposed mechanism for subcellular localization and organelle targeting.
    Mizejewski GJ
    J Theor Biol; 1995 Sep; 176(1):103-13. PubMed ID: 7475095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific secretion of gel-forming mucins and TFF peptides in HT-29 cells of mucin-secreting phenotype.
    Gouyer V; Wiede A; Buisine MP; Dekeyser S; Moreau O; Lesuffleur T; Hoffmann W; Huet G
    Biochim Biophys Acta; 2001 May; 1539(1-2):71-84. PubMed ID: 11389969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression.
    Fischer-Smith T; Tedaldi EM; Rappaport J
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):417-21. PubMed ID: 18373432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.
    Chinyama CN; Marshall RE; Owen WJ; Mason RC; Kothari D; Wilkinson ML; Sanderson JD
    Histopathology; 1999 Dec; 35(6):517-24. PubMed ID: 10583575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.